It is hard to imagine officials in the Department of Finance and maybe even the Department of Health ever thought the push for rebate reform might finally provide the evidence they have sought for ten years to prove some are engaged in the systematic monetisation of vial sharing.
Latest Video
New Stories
-
Neurizon Therapeutics entering 'a promising new horizon” as ALS program advances
November 26, 2025 - - Australian Biotech -
Slade Pharmacy marks anniversary with record research contributions at conferences
November 26, 2025 - - Latest News -
US secures significant price reductions on 15 medicines in second round of medicare negotiations
November 26, 2025 - - Latest News -
The US and UK edging close to an agreement on pharmaceutical pricing
November 26, 2025 - - Latest News -
US Medicare sets reimbursement price for PromarkerD, paving way for major commercial rollout
November 26, 2025 - - Australian Biotech -
Recce reports strong preclinical efficacy for inhaled R327 in hospital-acquired pneumonia model
November 26, 2025 - - Australian Biotech -
Race Oncology secures human ethics approval for lung cancer trial of RC220
November 26, 2025 - - Australian Biotech
